Latest
Recommended
Published: Wed, April 12, 2017
World | By 215

Masimo Receives Gates Foundation Subvention to Develop a Combined Pneumonia Detection Device for High-Load Environments | Business Wire


IRVINE, Calif. - (BUSINESS WIRE) - Massimo (NASDAQ: MASI) today announced ahead of World Pneumonia Day to be commemorated tomorrow that it has received a $ 4.95 million The Bill & amp; Melinda Gates Foundation (BMGF). The grant will support Masimo's efforts to develop a low-cost pulse oximeter for use in the detection of pneumonia in several low-resource areas outside the US. UU. While in development, the device is likely to measure oxygen saturation (SpO2 and respiration rate, RR), two key parameters that would provide additional information to clinicians when they detect possible cases of pneumonia in The grant will also support the study of the clinical use environment in such settings to ensure that the device is easy to use and fit for purpose.The grant may also support educational material to promote proper training and use of the device In all levels of literacy.

Pneumonia remains the leading cause of infectious treatable death in children worldwide and causes more than 900 000 deaths each year among children under 5 years of age. A study funded by BMGF Diagnostics Modeling Consortium, the researchers concluded that, in environments where oxygen is available In addition, adding pulse oximetry to standard integrated management of infant disease protocols could reduce pneumonia mortality rates. Recently, the World Health Organization (WHO) has sponsored an ongoing multi-country study to better evaluate how to improve community case management in the treatment of pneumonia.

Vaginitis: Causes, symptoms, and treatment - Medical News Today
For example, to condoms, spermicides, certain soaps and perfumes, douches, topical medications, lubricants, and even semen. The vagina is The muscular canal that runs from the cervix to the outside of the body, lined by a mucus membrane.

Rasa Izadnegahdar, Senior Program Officer on the BMGF Pneumonia Team, commented: "We are very pleased to partner with Masimo to improve the detection of pneumonia to enable better reference decisions of health workers in Low-resource settings.Assessing a child's rapid breathing is the cornerstone of evaluating pneumonia, and combining this with a reliable and effective approach to assessing oxygen saturation can have a significant impact in ensuring that children with pneumonia Receive appropriate care.Our review of the environment of pneumonia diagnostic assistive technologies has clearly demonstrated the poor performance of existing diagnostic aids, in particular respiratory rate timers.A diagnostic aid with sensitivity and specificity That are tailored and designed for use by health workers And caregivers can have a significant impact on the treatment of pneumonia. We look forward to working with Masimo to adapt its precise and accurate technology to respond to the needs of health workers, caregivers and children in countries where the burden of pneumonia and deaths remain unacceptably high. " >

Masimo SET Measure-through Motion and Low Perfusion ™ pulse oximetry is used to monitor millions of patients worldwide.This project demonstrates the company's firm commitment to reduce the unnecessarily high global burden of pneumonia Bringing their proven technology to detect and monitor patients to the areas of the world that need it the most.

Like this: